187 related articles for article (PubMed ID: 26310014)
1. [Vogt-Koyanagi-Harada syndrome (clinical cases)].
Sorokin EL; Voronina NV; Avramenko SY; Pomytkina NV
Vestn Oftalmol; 2015; 131(3):90-98. PubMed ID: 26310014
[TBL] [Abstract][Full Text] [Related]
2. Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
Chew SK; Levy J; Rogers S; Lim LL
Am J Ophthalmol; 2016 Jul; 167():52-6. PubMed ID: 27066721
[TBL] [Abstract][Full Text] [Related]
3. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
[TBL] [Abstract][Full Text] [Related]
4. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
Nakayama M; Keino H; Watanabe T; Okada AA
Br J Ophthalmol; 2019 Feb; 103(2):274-278. PubMed ID: 29666121
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravitreal dexamethasone implant in patients with Vogt-Koyanagi-Harada Disease and bilateral panuveitis: Two case reports.
Chen PL; Chen SN
Medicine (Baltimore); 2021 Oct; 100(40):e27394. PubMed ID: 34622843
[TBL] [Abstract][Full Text] [Related]
7. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
Montero JA; Sanchis ME; Fernandez-Munoz M
J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of anterior chamber depth measurement for efficacy assessment of steroid pulse therapy in patients with Vogt-Koyanagi-Harada disease.
Otsuki T; Shimizu K; Igarashi A; Kamiya K
Jpn J Ophthalmol; 2010 Sep; 54(5):396-400. PubMed ID: 21052900
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
11. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
Retina; 2016 Feb; 36(2):415-21. PubMed ID: 26352553
[TBL] [Abstract][Full Text] [Related]
12. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
[TBL] [Abstract][Full Text] [Related]
13. [Vogt-Koyanagi-Harada disease].
Kjeka O; Krohn J
Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
[TBL] [Abstract][Full Text] [Related]
14. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
15. Vitreous surgery for bilateral bullous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Gaun S; Kurimoto Y; Komurasaki Y; Yoshimura N
Ophthalmic Surg Lasers; 2002; 33(6):508-10. PubMed ID: 12449230
[TBL] [Abstract][Full Text] [Related]
16. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease.
Nakayama M; Keino H; Okada AA; Watanabe T; Taki W; Inoue M; Hirakata A
Retina; 2012; 32(10):2061-9. PubMed ID: 23095726
[TBL] [Abstract][Full Text] [Related]
17. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T; Fujiwara T; Spaide RF
Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
[TBL] [Abstract][Full Text] [Related]
18. Successive onset of Vogt-Koyanagi-Harada syndrome in father and son.
Li H; Sun S; Zhang Y; Liu J; Zhao X; Zhao G
BMC Ophthalmol; 2023 Mar; 23(1):113. PubMed ID: 36944975
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
[TBL] [Abstract][Full Text] [Related]
20. Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
Gruich MJ; Evans OB; Storey JM; Bradley ST; Chen CJ
Pediatr Neurol; 1995 Jul; 13(1):50-1. PubMed ID: 7575849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
